Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)
China · Delayed Price · Currency is CNY 27.05
-0.38 (-1.39%)
Jun 11, 2026, 3:04 PM CST
SHE:002864 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 86.79 | 96.28 | 120.27 | 110.43 | 101.16 | 93.17 |
Depreciation & Amortization | 36.74 | 36.74 | 32.97 | 31.05 | 18.31 | 16.85 |
Other Amortization | 0.63 | 0.63 | 0.48 | 0.19 | 0.02 | 0.08 |
Loss (Gain) From Sale of Assets | -0.13 | -0.13 | 0.01 | -0.17 | - | - |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.18 | 5.7 | 0.08 | 0 |
Loss (Gain) From Sale of Investments | 0.13 | 0.13 | -0.63 | 1.56 | 0.11 | - |
Provision & Write-off of Bad Debts | 23.98 | 23.98 | 1.85 | - | 8.36 | 4.61 |
Other Operating Activities | 78.93 | 2.4 | 1.81 | 5.6 | 12.25 | 5.89 |
Change in Accounts Receivable | -121.29 | -121.29 | -12.48 | -46.14 | -94.42 | -56.67 |
Change in Inventory | -15.41 | -15.41 | -18.21 | 4.97 | -28.1 | -0.46 |
Change in Accounts Payable | 46.85 | 46.85 | 29.16 | -14.63 | 104.67 | 55.81 |
Change in Other Net Operating Assets | -2.76 | -2.76 | -0.89 | 1.96 | 1.69 | - |
Operating Cash Flow | 130.05 | 63.01 | 156.59 | 104.05 | 125.36 | 116.04 |
Operating Cash Flow Growth | 9.21% | -59.76% | 50.50% | -17.00% | 8.04% | 25.80% |
Capital Expenditures | -28.46 | -42.41 | -82.05 | -62.51 | -55.84 | -80.68 |
Sale of Property, Plant & Equipment | 0.28 | 0.28 | 0 | 0.15 | 0.03 | 0.03 |
Cash Acquisitions | - | - | -23.49 | - | - | -5.1 |
Divestitures | - | - | 0.03 | - | - | - |
Investment in Securities | - | - | - | 2.39 | -10 | - |
Other Investing Activities | - | - | 2 | -2.44 | 28.24 | - |
Investing Cash Flow | -28.18 | -42.12 | -103.51 | -62.41 | -37.57 | -85.75 |
Long-Term Debt Issued | - | 50 | 150 | 134.17 | 431.69 | 50.74 |
Total Debt Issued | 150 | 50 | 150 | 134.17 | 431.69 | 50.74 |
Long-Term Debt Repaid | - | -101.4 | -100.9 | -169.89 | -108.93 | -14.17 |
Total Debt Repaid | -149.4 | -101.4 | -100.9 | -169.89 | -108.93 | -14.17 |
Net Debt Issued (Repaid) | 0.6 | -51.4 | 49.1 | -35.73 | 322.77 | 36.57 |
Issuance of Common Stock | - | - | - | 297.25 | 15.07 | - |
Repurchase of Common Stock | -0.58 | -0.58 | -10.3 | -0.06 | - | -10.1 |
Common Dividends Paid | -38.55 | -43.89 | -24.52 | -24.3 | -21.09 | -17.89 |
Other Financing Activities | 1.07 | 0.5 | - | -0.24 | -0.4 | -1.56 |
Financing Cash Flow | -37.45 | -95.37 | 14.28 | 236.93 | 316.35 | 7.01 |
Net Cash Flow | 64.42 | -74.48 | 67.36 | 278.57 | 404.14 | 37.3 |
Free Cash Flow | 101.59 | 20.6 | 74.54 | 41.53 | 69.53 | 35.36 |
Free Cash Flow Growth | 154.08% | -72.36% | 79.47% | -40.26% | 96.63% | 67.91% |
Free Cash Flow Margin | 9.13% | 1.81% | 7.65% | 4.23% | 7.14% | 3.98% |
Free Cash Flow Per Share | 0.97 | 0.20 | 0.71 | 0.42 | 0.80 | 0.41 |
Cash Income Tax Paid | 109.47 | 99.63 | 98.83 | 95.65 | 93.22 | 84.74 |
Levered Free Cash Flow | 68.37 | -30.17 | 4.53 | -2.9 | 72.68 | -17.87 |
Unlevered Free Cash Flow | 69.6 | -28.8 | 5.5 | 0.92 | 81.38 | -15.68 |
Change in Working Capital | -97.04 | -97.04 | -0.35 | -50.31 | -14.94 | -4.57 |